companydata.dkONCONOX ApS: Financial statements 2018
CVR: 33858965
ONCONOX ApS (CVR 33858965) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 0 and a net result of DKK -1,029,467 compared with DKK 393,163 the year before. Equity amounted to DKK 29,193. The solvency ratio was 48.1%.
- Gross Profit
- 0 kr.
- Profit/Loss
- -1,029,467 kr.
- Equity
- 29,193 kr.
- Total Assets
- 60,693 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 0 | -1 mio. | 29 t. | - |
| 2017 | - | 547 t. | 393 t. | 1.1 mio. | - |
| 2016 | - | 0 | -15 t. | 995 t. | - |
| 2015 | - | - | 1.5 mio. | 1 mio. | - |
| 2014 | - | - | -50 t. | -93 | - |
Keep an eye on ONCONOX ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
As of December 21, 2018, Ferdinando Nicoletti has joined the board of directors of ONCONOX ApS.
As of December 21, 2018, Gianni Garotta has left the board of directors of ONCONOX ApS.
As of December 20, 2018, Ferdinando Nicoletti has left the board of directors of ONCONOX ApS.
ONCONOX ApS has published its annual report for 2017. Gross profit came to DKK 547,382, and the net result was DKK 393,163.
About ONCONOX ApS
ONCONOX ApS was a Danish company of the type Anpartsselskab based in Greve, founded in 2011. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company is owned by Amme Pharmaceuticals, Inc.. The company has 0 employees. In 2022, the company reported a net result of DKK -40,672 compared with DKK -43,846 the year before. Equity amounted to DKK -4,305.